Cognios Beta Neutral Large Cap Fund’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$551K Sell
4,925
-704
-13% -$76K 0.72% 38
2023
Q4
$567K Sell
5,629
-671
-11% -$66.6K 0.74% 46
2023
Q3
$547K Sell
6,300
-1,243
-16% -$112K 0.71% 69
2023
Q2
$713K Sell
7,543
-1,574
-17% -$133K 0.83% 48
2023
Q1
$687K Buy
+9,117
New +$688K 0.65% 76

Other funds holding CAH

Cognios Beta Neutral Large Cap Fund's CAH Position: Q1 2024 in Review

Cognios Beta Neutral Large Cap Fund reduced its Cardinal Health (CAH) stake by 13% in Q1 2024, selling an estimated $76K and leaving 4,925 shares worth $551K. The position accounts for 0.72% of the portfolio, ranked #38.

Cognios Beta Neutral Large Cap Fund first reported a position in CAH in Q1 2023 and has held it in 5 quarters since. The position peaked at $713K in Q2 2023. 1,058 funds tracked by Wall St. Rank hold CAH as of Q1 2024.

  • Cognios Beta Neutral Large Cap Fund held 4,925 shares of Cardinal Health worth $551K as of Q1 2024.
  • Cognios Beta Neutral Large Cap Fund sold 704 Cardinal Health shares in Q1 2024, an estimated $76K.
  • Cardinal Health made up 0.72% of Cognios Beta Neutral Large Cap Fund's portfolio in Q1 2024, its #38 holding.
  • Cognios Beta Neutral Large Cap Fund first reported a position in Cardinal Health in Q1 2023 and has held it in 5 quarters since.
  • Cognios Beta Neutral Large Cap Fund's Cardinal Health position peaked at $713K in Q2 2023.
  • 1,058 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2024.

Based on Cognios Beta Neutral Large Cap Fund's 13F filing for Q1 2024, filed 8 May 2024.